S
Sergio Ricci
Researcher at University of Pisa
Publications - 87
Citations - 17024
Sergio Ricci is an academic researcher from University of Pisa. The author has contributed to research in topics: Sorafenib & Cancer. The author has an hindex of 28, co-authored 87 publications receiving 14757 citations. Previous affiliations of Sergio Ricci include Bayer.
Papers
More filters
Journal ArticleDOI
Safety and antitumor efficacy of 153Sm-EDTMP and docetaxel administered sequentially to patients with metastatic castration-resistant prostate cancer
Elisa Borsò,Giuseppe Boni,Ilaria Pastina,Alice Lorenzoni,C. Cianci,Francesca Federici,Sara Mazzarri,Cinzia Orlandini,Francesco Francesca,Cesare Selli,Sergio Ricci,Domenico Rubello,Giuliano Mariani +12 more
TL;DR: Prior administration of 153Sm-EDTMP does not cause additional toxicities for subsequent treatment with docetaxel and does not reduce the antitumor efficacy of the latter, which justifies further investigations on the possible synergistic effects of combined strategies with the two agents.
Journal ArticleDOI
Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancer.
Elizabeth H. Baldini,Carmelo Tibaldi,Elisabetta Pfanner,Sergio Ricci,Alfredo Falcone,Anna Ceribelli,R. Sarcina,G. Comella,Corrado Gallo Stampino,Pierfranco Conte +9 more
TL;DR: It is demonstrated that a home therapy with oral doxifluridine in elderly NSCLC patients is feasible and well tolerated and should encourage further studies.
Journal ArticleDOI
Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study.
Francesco Pantano,Paolo Manca,Grazia Armento,Tea Zeppola,Angelo Onorato,Michele Iuliani,Sonia Simonetti,Bruno Vincenzi,Daniele Santini,Sebastiano Mercadante,Paolo Marchetti,Arturo Cuomo,Augusto Caraceni,Rocco Domenico Mediati,Renato Vellucci,Massimo Mammucari,Silvia Natoli,Marzia Lazzari,Mario Dauri,Claudio Adile,Mario Airoldi,Giuseppe Azzarello,Livio Blasi,Bruno Chiurazzi,Daniela Degiovanni,Flavio Fusco,Vittorio Guardamagna,Simeone Liguori,Loredana Palermo,Sergio Mameli,Francesco Masedu,Teresita Mazzei,Rita Maria Melotti,Valentino Menardo,Danilo Miotti,S. Moroso,Gaetano Pascoletti,Stefano De Santis,Remo Orsetti,Alfonso Papa,Sergio Ricci,Elvira Scelzi,Michele Sofia,Federica Aielli,Alessandro Valle,Giuseppe Tonini +45 more
TL;DR: This work supports the theory that the optimal dose of BTcP opioids depends on the dose of basal opioids and identifies novel values that are possibly useful for future trials.
Journal Article
Off-label use of sunitinib in patients with advanced epithelial thyroid cancer: a retrospective analysis
Giuseppe Pasqualetti,Sergio Ricci,Giuseppe Boni,Sara Tognini,Antonio Polini,Giuliano Mariani,Marco Ferdeghini,Fabio Monzani +7 more
TL;DR: Sunitinib is a novel tyrosine kinase inhibitor, approved in 2006 by Food and Drug Administration for the treatment of advanced renal cell and gastrointestinal stromal tumors as mentioned in this paper.
Journal ArticleDOI
Supportive care and not only palliative care in the route of cancer patients.
Andrea Antonuzzo,Maurizio Lucchesi,Isa Brunetti,Luca Galli,Enrico Vasile,Francesca Bonci,Sergio Ricci,Alfredo Falcone +7 more
TL;DR: Supportive care and palliative care share the common goal of providing the best possible quality of life by maximizing patient’s comfort and minimizing suffering, but despite the strong similarities, the differences are not only in terms of semantic definition.